Difficulty: Medium
Average Score: 84%
Practice
A 58-year-old woman with multiple sclerosis presents to her primary care physician for follow-up. She ambulates well and has few issues with her disease. Which of the following agents may be beneficial in slowing the progression of this disease?
Correct answer
B
Rationale
Fingolimod is an immunomodulatory agent that reduces the frequency of relapses in multiple sclerosis by preventing lymphocytes from entering the central nervous system.